Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All fluvoxamine studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchFluvoxamineFluvoxamine (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Paxlovid Meta
Famotidine Meta Quercetin Meta
Favipiravir Meta Remdesivir Meta
Fluvoxamine Meta Thermotherapy Meta
Hydroxychlor.. Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Protective Effect of Fluvoxamine for COVID-19 in Obsessive-Compulsive Disorder

Diaz et al., The Primary Care Companion For CNS Disorders, doi:10.4088/PCC.22br03337
Oct 2022  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Case 28% Improvement Relative Risk Fluvoxamine for COVID-19  Diaz et al.  Prophylaxis Does fluvoxamine reduce COVID-19 infections? PSM retrospective 82,069 patients in the USA Fewer cases with fluvoxamine (p<0.000001) c19early.org Diaz et al., The Primary Care Companio.., Oct 2022 Favorsfluvoxamine Favorscontrol 0 0.5 1 1.5 2+
27th treatment shown to reduce risk in November 2021
 
*, now with p = 0.00014 from 21 studies, recognized in 3 countries.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,400+ studies for 79 treatments. c19early.org
TriNetX PSM retrospective 82,069 OCD patients, showing lower risk of COVID-19 with fluvoxamine use.
risk of case, 28.0% lower, OR 0.72, p < 0.001, treatment 4,558, control 4,558, propensity score matching, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Diaz et al., 6 Oct 2022, retrospective, USA, peer-reviewed, 2 authors.
This PaperFluvoxamineAll
{ 'indexed': {'date-parts': [[2022, 9, 29]], 'date-time': '2022-09-29T22:11:28Z', 'timestamp': 1664489488944}, 'reference-count': 0, 'publisher': 'Physicians Postgraduate Press, Inc', 'issue': '5', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'DOI': '10.4088/pcc.22br03337', 'type': 'journal-article', 'created': {'date-parts': [[2022, 9, 29]], 'date-time': '2022-09-29T21:33:32Z', 'timestamp': 1664487212000}, 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Protective Effect of Fluvoxamine for COVID-19 in Obsessive-Compulsive Disorder', 'prefix': '10.4088', 'volume': '24', 'author': [ {'given': 'Ailyn D.', 'family': 'Diaz', 'sequence': 'first', 'affiliation': []}, {'given': 'Raman', 'family': 'Baweja', 'sequence': 'additional', 'affiliation': []}], 'member': '2558', 'published-online': {'date-parts': [[2022, 10, 6]]}, 'container-title': 'The Primary Care Companion For CNS Disorders', 'original-title': [], 'deposited': { 'date-parts': [[2022, 9, 29]], 'date-time': '2022-09-29T21:33:32Z', 'timestamp': 1664487212000}, 'score': 1, 'resource': { 'primary': { 'URL': 'https://www.psychiatrist.com/pcc/ocd/protective-effect-fluvoxamine-covid-19-obsessive-compulsive-disorder-real-world-case-control-study/'}}, 'subtitle': ['A Real-World Case-Control Study'], 'short-title': [], 'issued': {'date-parts': [[2022, 10, 6]]}, 'references-count': 0, 'journal-issue': {'issue': '5', 'published-online': {'date-parts': [[2022, 10, 6]]}}, 'URL': 'http://dx.doi.org/10.4088/PCC.22br03337', 'relation': {}, 'ISSN': ['2155-7780'], 'subject': ['General Medicine'], 'container-title-short': 'Prim. Care Companion CNS Disord.', 'published': {'date-parts': [[2022, 10, 6]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit